H. W. Lim

Prevention of cardiac hypertrophy in mice by calcineurin inhibition.

Mark A Sussman, E. Olson, N. Gude, 1998, Science.

Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.

Mark A Sussman, L. D. de Windt, T. Kimball, 2000, Journal of molecular and cellular cardiology.

Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure.

G. Condorelli, G. Dorn, R. Kitsis, 2000, Circulation research.

Characterization of the ATP transporter in the reconstituted rough endoplasmic reticulum proteoliposomes.

J. Park, S. Shin, W. K. Lee, 2000, Biochimica et biophysica acta.

Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.

J. Molkentin, L. D. de Windt, L. Windt, 2000, Circulation.

Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.

J. Molkentin, L. D. de Windt, L. Windt, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Pathogenesis of dilated cardiomyopathy: molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice.

S. Daniels, R. Price, Mark A Sussman, 1999, The American journal of pathology.

Identification of differentially expressed mRNA during pancreas regeneration of rat by mRNA differential display.

S. Shin, J. Seong, S. Oh, 2002, Biochemical and biophysical research communications.

Hypertrophic defect unmasked by calcineurin expression in asymptomatic tropomodulin overexpressing transgenic mice.

T. Hewett, R. Price, Mark A Sussman, 2000, Cardiovascular research.

Uncoupling of oxidative phosphorylation by curcumin: implication of its cellular mechanism of action.

K. P. Wong, H. Lim, H. W. Lim, 2009, Biochemical and biophysical research communications.